159 related articles for article (PubMed ID: 38760801)
1. Association between metabolic syndrome and kidney cancer risk: a prospective cohort study.
Wang L; Du H; Sheng C; Dai H; Chen K
Lipids Health Dis; 2024 May; 23(1):142. PubMed ID: 38760801
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome and risk of Parkinson disease: A nationwide cohort study.
Nam GE; Kim SM; Han K; Kim NH; Chung HS; Kim JW; Han B; Cho SJ; Yu JH; Park YG; Choi KM
PLoS Med; 2018 Aug; 15(8):e1002640. PubMed ID: 30130376
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome and its component traits present gender-specific association with liver cancer risk: a prospective cohort study.
Xia B; Peng J; Enrico T; Lu K; Cheung EC; Kuo Z; He Q; Tang Y; Liu A; Fan D; Zhang C; He Y; Pan Y; Yuan J
BMC Cancer; 2021 Oct; 21(1):1084. PubMed ID: 34620113
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome increases osteoarthritis risk: findings from the UK Biobank prospective cohort study.
Zhang S; Wang D; Zhao J; Zhao H; Xie P; Zheng L; Sheng P; Yuan J; Xia B; Wei F; Zhang Z
BMC Public Health; 2024 Jan; 24(1):233. PubMed ID: 38243159
[TBL] [Abstract][Full Text] [Related]
5. Patterns of Cardiometabolic Health as Midlife Women Transition to Menopause: A Prospective Multiethnic Study.
Ward E; Gold EB; Johnson WO; Ding F; Chang PY; Song P; El Khoudary SR; Karvonen-Gutierrez C; Ylitalo KR; Lee JS
J Clin Endocrinol Metab; 2019 May; 104(5):1404-1412. PubMed ID: 30365014
[TBL] [Abstract][Full Text] [Related]
6. Components of metabolic syndrome and prognosis of renal cell cancer.
Eskelinen TJ; Kotsar A; Tammela TLJ; Murtola TJ
Scand J Urol; 2017 Dec; 51(6):435-441. PubMed ID: 28743221
[TBL] [Abstract][Full Text] [Related]
7. Association of metabolic syndrome and its components with the risk of urologic cancers: a prospective cohort study.
Jiang R; Wang X; Li Z; Cai H; Sun Z; Wu S; Chen S; Hu H
BMC Urol; 2023 Sep; 23(1):150. PubMed ID: 37736725
[TBL] [Abstract][Full Text] [Related]
8. [Incidence of metabolic syndrome and associated lifestyle factors in a worksite male population].
Otsuka T; Kawada T; Yanai M; Kitagawa Y; Kan H
Sangyo Eiseigaku Zasshi; 2011; 53(3):78-86. PubMed ID: 21372516
[TBL] [Abstract][Full Text] [Related]
9. Predictors of Lipid Profile Abnormalities Among Patients with Metabolic Syndrome in Southwest Ethiopia: A Cross-Sectional Study.
Haile K; Haile A; Timerga A
Vasc Health Risk Manag; 2021; 17():461-469. PubMed ID: 34393487
[TBL] [Abstract][Full Text] [Related]
10. Investigating the nexus of metabolic syndrome, serum uric acid, and dementia risk: a prospective cohort study.
Chen TS; Mi NN; Lao HY; Wang CY; Lo WLA; Mao YR; Tang Y; Pei Z; Yuan JQ; Huang DF
BMC Med; 2024 Mar; 22(1):115. PubMed ID: 38481272
[TBL] [Abstract][Full Text] [Related]
11. Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population.
Liu CS; Hsu HS; Li CI; Jan CI; Li TC; Lin WY; Lin T; Chen YC; Lee CC; Lin CC
BMC Gastroenterol; 2010 May; 10():51. PubMed ID: 20507579
[TBL] [Abstract][Full Text] [Related]
12. Number of Metabolic Syndrome Components Is the Central Predictor of the Impact of Metabolic Syndrome on Outcome of Percutaneous Nephrolithotomy in Staghorn Nephrolithiasis.
Xu P; Wang J
J Endourol; 2019 Nov; 33(11):946-953. PubMed ID: 31333070
[No Abstract] [Full Text] [Related]
13. Metabolic syndrome components and diabetes incidence according to the presence or absence of impaired fasting glucose: The Japan Epidemiology Collaboration on Occupational Health Study.
Kurotani K; Miyamoto T; Kochi T; Eguchi M; Imai T; Nishihara A; Tomita K; Uehara A; Yamamoto M; Murakami T; Shimizu C; Shimizu M; Nagahama S; Nakagawa T; Honda T; Yamamoto S; Okazaki H; Sasaki N; Hori A; Nishiura C; Kuwahara K; Kuroda R; Akter S; Kashino I; Nanri A; Kabe I; Mizoue T; Kunugita N; Dohi S;
J Epidemiol; 2017 Sep; 27(9):408-412. PubMed ID: 28434837
[TBL] [Abstract][Full Text] [Related]
14. Central obesity is important but not essential component of the metabolic syndrome for predicting diabetes mellitus in a hypertensive family-based cohort. Results from the Stanford Asia-pacific program for hypertension and insulin resistance (SAPPHIRe) Taiwan follow-up study.
Lee IT; Chiu YF; Hwu CM; He CT; Chiang FT; Lin YC; Assimes T; Curb JD; Sheu WH
Cardiovasc Diabetol; 2012 Apr; 11():43. PubMed ID: 22537054
[TBL] [Abstract][Full Text] [Related]
15. The associations of metabolic syndrome with incident hypertension, type 2 diabetes mellitus and chronic kidney disease: a cohort study.
Ding C; Yang Z; Wang S; Sun F; Zhan S
Endocrine; 2018 May; 60(2):282-291. PubMed ID: 29492904
[TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome and risk of pancreatic cancer: A population-based prospective cohort study.
Xia B; He Q; Pan Y; Gao F; Liu A; Tang Y; Chong C; Teoh AYB; Li F; He Y; Zhang C; Yuan J
Int J Cancer; 2020 Dec; 147(12):3384-3393. PubMed ID: 32580250
[TBL] [Abstract][Full Text] [Related]
17. The Association between Plant-Based Diet Indices and Metabolic Syndrome in Chinese Adults: Longitudinal Analyses from the China Health and Nutrition Survey.
Huo Y; Cao S; Liu J; Zhang B; Xu K; Wang Y; Liu H; Yang P; Zeng L; Yan H; Dang S; Mi B
Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986071
[TBL] [Abstract][Full Text] [Related]
18. Association of elective cesarean delivery with metabolic measures in childhood: A prospective cohort study in China.
Zhou YB; Li HT; Si KY; Zhang YL; Wang LL; Liu JM
Nutr Metab Cardiovasc Dis; 2019 Aug; 29(8):775-782. PubMed ID: 31151881
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome and the risk of urothelial carcinoma of the bladder: a case-control study.
Montella M; Di Maso M; Crispo A; Grimaldi M; Bosetti C; Turati F; Giudice A; Libra M; Serraino D; La Vecchia C; Tambaro R; Cavalcanti E; Ciliberto G; Polesel J
BMC Cancer; 2015 Oct; 15():720. PubMed ID: 26475132
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome and risk of endometrial cancer in postmenopausal women: a prospective study.
Arthur RS; Kabat GC; Kim MY; Wild RA; Shadyab AH; Wactawski-Wende J; Ho GYF; Reeves KW; Kuller LH; Luo J; Beebe-Dimmer J; Simon MS; Strickler H; Wassertheil-Smoller S; Rohan TE
Cancer Causes Control; 2019 Apr; 30(4):355-363. PubMed ID: 30788634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
